AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Revolution Medicines, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Worthington Steel, Inc. (WS) has filed a Form 4 indicating that Executive Chairman and Director John B. Blystone received 17,065 restricted common shares on 06/27/2025 pursuant to the company’s 2023 Long-Term Incentive Plan. The transaction is coded “A,â€� signifying an equity award granted at $0 rather than an open-market purchase. After the grant, Blystone’s direct beneficial ownership rises to 236,314 shares. The award will vest on 06/27/2026, strengthening the executive’s equity stake and aligning leadership incentives with shareholders. No sales, option exercises, or derivative transactions were reported in this filing.

Worthington Steel, Inc. (WS) ha presentato un Modulo 4 che indica che il Presidente Esecutivo e Direttore John B. Blystone ha ricevuto 17.065 azioni ordinarie vincolate il 27/06/2025, in conformità con il Piano di Incentivi a Lungo Termine 2023 della società. La transazione è contrassegnata con il codice “A�, che indica un premio azionario concesso a $0 anziché un acquisto sul mercato aperto. Dopo l'assegnazione, la proprietà diretta effettiva di Blystone sale a 236.314 azioni. Il premio maturerà il 27/06/2026, rafforzando la partecipazione azionaria dell'esecutivo e allineando gli incentivi della leadership con quelli degli azionisti. In questa comunicazione non sono state segnalate vendite, esercizi di opzioni o transazioni su derivati.

Worthington Steel, Inc. (WS) ha presentado un Formulario 4 que indica que el Presidente Ejecutivo y Director John B. Blystone °ù±ð³¦¾±²ú¾±Ã³ 17,065 acciones ordinarias restringidas el 27/06/2025 según el Plan de Incentivos a Largo Plazo 2023 de la compañía. La transacción está codificada como “Aâ€�, lo que significa una concesión de acciones a $0 en lugar de una compra en el mercado abierto. Tras la concesión, la propiedad directa beneficiosa de Blystone aumenta a 236,314 acciones. La concesión se consolidará el 27/06/2026, fortaleciendo la participación accionaria del ejecutivo y alineando los incentivos del liderazgo con los de los accionistas. No se reportaron ventas, ejercicios de opciones ni transacciones con derivados en esta presentación.

Worthington Steel, Inc. (WS)ëŠ� ìž„ì› íšŒìž¥ ê²� ì´ì‚¬ì� John B. Blystoneê°€ 2023ë…� 장기 ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ 2025ë…� 6ì›� 27ì¼ì— 17,065ì£¼ì˜ ì œí•œë� 보통ì£�ë¥� 받았ìŒì„ 나타내는 Form 4ë¥� 제출했습니다. 거래 코드ëŠ� “Aâ€ë¡œ, ì´ëŠ” 공개 시장ì—서ì� 매수가 아닌 0달러ë¡� ë¶€ì—¬ëœ ì£¼ì‹ ë³´ìƒìž„ì„ ì˜ë¯¸í•©ë‹ˆë‹�. ë¶€ì—� í›� Blystoneì� ì§ì ‘ 실질 소유주ì‹ì¶Ä 236,314ì£�ë¡� ì¦ê°€í•©ë‹ˆë‹�. ì� ë³´ìƒì¶Ä 2026ë…� 6ì›� 27ì¼ì— 권리 확정ë˜ì–´ ìž„ì›ì� ì§€ë¶„ì„ ê°•í™”í•˜ê³  ê²½ì˜ì§„ì˜ ì¸ì„¼í‹°ë¸Œë¥� 주주와 ì¼ì¹˜ì‹œí‚µë‹ˆë‹¤. ì´ë²ˆ 제출서ì—ëŠ� 매ë„, 옵션 행사 ë˜ëŠ” 파ìƒìƒí’ˆ 거래가 ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Worthington Steel, Inc. (WS) a déposé un formulaire 4 indiquant que le président exécutif et administrateur John B. Blystone a reçu 17 065 actions ordinaires restreintes le 27/06/2025 conformément au Plan d'incitation à long terme 2023 de l'entreprise. La transaction est codée « A », signifiant une attribution d'actions à 0 $ plutôt qu'un achat sur le marché libre. Après cette attribution, la possession directe effective de Blystone s'élève à 236 314 actions. L'attribution sera acquise le 27/06/2026, renforçant la participation de l'exécutif et alignant les incitations de la direction avec celles des actionnaires. Aucune vente, exercice d'option ou transaction sur dérivés n'a été signalée dans ce dépôt.

Worthington Steel, Inc. (WS) hat ein Formular 4 eingereicht, das angibt, dass der Executive Chairman und Direktor John B. Blystone am 27.06.2025 17.065 eingeschränkte Stammaktien gemäß dem langfristigen Anreizplan 2023 des Unternehmens erhalten hat. Die Transaktion ist mit „A� codiert, was eine Aktienzuteilung zu 0 $ und keinen Kauf am freien Markt bedeutet. Nach der Zuteilung steigt Blystones direkter wirtschaftlicher Eigentumsanteil auf 236.314 Aktien. Die Zuteilung wird am 27.06.2026 fällig und stärkt den Aktienanteil des Executives sowie die Ausrichtung der Führungskräfteanreize auf die Aktionäre. In dieser Meldung wurden keine Verkäufe, Optionsausübungen oder Derivatgeschäfte angegeben.

Positive
  • Executive Chairman increased direct holdings by 17,065 shares, bringing his stake to 236,314 shares, enhancing insider alignment.
  • Restricted stock vests in one year, providing a retention and performance incentive without immediate shareholder dilution.
Negative
  • None.

Insights

TL;DR � 17,065-share restricted stock award adds to insider stake; neutral short-term impact.

The award increases the Executive Chairman’s direct ownership to 236,314 shares, but because it is a zero-cost grant rather than an open-market buy, near-term valuation impact is limited. Still, a larger equity position marginally improves alignment incentives, which can be viewed as a modest positive governance signal. No cash outflow or earnings effect is involved, so the market reaction is likely muted.

TL;DR � Standard annual equity grant; aligns pay with performance, limited strategic signal.

The use of restricted stock that vests after one year reflects common best practice for executive compensation, encouraging retention and long-term focus. The single-year cliff vest is shorter than multi-year tranches seen at larger peers, indicating a relatively near-term alignment horizon. Because the award is routine and represents a small percentage of outstanding shares, I classify the disclosure as not materially impactful for governance risk assessments.

Worthington Steel, Inc. (WS) ha presentato un Modulo 4 che indica che il Presidente Esecutivo e Direttore John B. Blystone ha ricevuto 17.065 azioni ordinarie vincolate il 27/06/2025, in conformità con il Piano di Incentivi a Lungo Termine 2023 della società. La transazione è contrassegnata con il codice “A�, che indica un premio azionario concesso a $0 anziché un acquisto sul mercato aperto. Dopo l'assegnazione, la proprietà diretta effettiva di Blystone sale a 236.314 azioni. Il premio maturerà il 27/06/2026, rafforzando la partecipazione azionaria dell'esecutivo e allineando gli incentivi della leadership con quelli degli azionisti. In questa comunicazione non sono state segnalate vendite, esercizi di opzioni o transazioni su derivati.

Worthington Steel, Inc. (WS) ha presentado un Formulario 4 que indica que el Presidente Ejecutivo y Director John B. Blystone °ù±ð³¦¾±²ú¾±Ã³ 17,065 acciones ordinarias restringidas el 27/06/2025 según el Plan de Incentivos a Largo Plazo 2023 de la compañía. La transacción está codificada como “Aâ€�, lo que significa una concesión de acciones a $0 en lugar de una compra en el mercado abierto. Tras la concesión, la propiedad directa beneficiosa de Blystone aumenta a 236,314 acciones. La concesión se consolidará el 27/06/2026, fortaleciendo la participación accionaria del ejecutivo y alineando los incentivos del liderazgo con los de los accionistas. No se reportaron ventas, ejercicios de opciones ni transacciones con derivados en esta presentación.

Worthington Steel, Inc. (WS)ëŠ� ìž„ì› íšŒìž¥ ê²� ì´ì‚¬ì� John B. Blystoneê°€ 2023ë…� 장기 ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ 2025ë…� 6ì›� 27ì¼ì— 17,065ì£¼ì˜ ì œí•œë� 보통ì£�ë¥� 받았ìŒì„ 나타내는 Form 4ë¥� 제출했습니다. 거래 코드ëŠ� “Aâ€ë¡œ, ì´ëŠ” 공개 시장ì—서ì� 매수가 아닌 0달러ë¡� ë¶€ì—¬ëœ ì£¼ì‹ ë³´ìƒìž„ì„ ì˜ë¯¸í•©ë‹ˆë‹�. ë¶€ì—� í›� Blystoneì� ì§ì ‘ 실질 소유주ì‹ì¶Ä 236,314ì£�ë¡� ì¦ê°€í•©ë‹ˆë‹�. ì� ë³´ìƒì¶Ä 2026ë…� 6ì›� 27ì¼ì— 권리 확정ë˜ì–´ ìž„ì›ì� ì§€ë¶„ì„ ê°•í™”í•˜ê³  ê²½ì˜ì§„ì˜ ì¸ì„¼í‹°ë¸Œë¥� 주주와 ì¼ì¹˜ì‹œí‚µë‹ˆë‹¤. ì´ë²ˆ 제출서ì—ëŠ� 매ë„, 옵션 행사 ë˜ëŠ” 파ìƒìƒí’ˆ 거래가 ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Worthington Steel, Inc. (WS) a déposé un formulaire 4 indiquant que le président exécutif et administrateur John B. Blystone a reçu 17 065 actions ordinaires restreintes le 27/06/2025 conformément au Plan d'incitation à long terme 2023 de l'entreprise. La transaction est codée « A », signifiant une attribution d'actions à 0 $ plutôt qu'un achat sur le marché libre. Après cette attribution, la possession directe effective de Blystone s'élève à 236 314 actions. L'attribution sera acquise le 27/06/2026, renforçant la participation de l'exécutif et alignant les incitations de la direction avec celles des actionnaires. Aucune vente, exercice d'option ou transaction sur dérivés n'a été signalée dans ce dépôt.

Worthington Steel, Inc. (WS) hat ein Formular 4 eingereicht, das angibt, dass der Executive Chairman und Direktor John B. Blystone am 27.06.2025 17.065 eingeschränkte Stammaktien gemäß dem langfristigen Anreizplan 2023 des Unternehmens erhalten hat. Die Transaktion ist mit „A� codiert, was eine Aktienzuteilung zu 0 $ und keinen Kauf am freien Markt bedeutet. Nach der Zuteilung steigt Blystones direkter wirtschaftlicher Eigentumsanteil auf 236.314 Aktien. Die Zuteilung wird am 27.06.2026 fällig und stärkt den Aktienanteil des Executives sowie die Ausrichtung der Führungskräfteanreize auf die Aktionäre. In dieser Meldung wurden keine Verkäufe, Optionsausübungen oder Derivatgeschäfte angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Horning Sandra

(Last) (First) (Middle)
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DR

(Street)
REDWOOD CITY CA 94063

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 A 3,142 A $0 96,574(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $37.48 06/26/2025 A 11,574 (2) 06/26/2035 Common Stock 11,574 $0 11,574 D
Explanation of Responses:
1. Includes 8,392 Restricted Stock Units.
2. Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
/s/ Jack Anders, as Attorney-in-fact for Sandra Horning 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Worthington Steel (WS) shares did Executive Chairman John B. Blystone acquire?

He was granted 17,065 restricted common shares on 06/27/2025.

What is John B. Blystone’s total direct beneficial ownership after the transaction?

Following the award, he directly owns 236,314 WS shares.

What transaction code appears in the Form 4 for this grant?

The filing lists transaction code "A", indicating an equity award or acquisition from the issuer.

When will the restricted shares granted to Blystone vest?

The restricted stock will vest on 06/27/2026, one year after the grant date.

Was any cash paid for the newly acquired shares?

No. The restricted stock was granted at a price of $0 per share.
Revolution Medicines, Inc.

NASDAQ:RVMD

RVMD Rankings

RVMD Latest News

RVMD Latest SEC Filings

RVMD Stock Data

6.99B
181.47M
2.06%
106.38%
8.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
REDWOOD CITY